Dexcom Inc (DXCM) Files Form 4 Insider Selling : Terrance H Gregg Sells 2,169 Shares

Dexcom Inc (DXCM): Terrance H Gregg , Executive Chairman of Dexcom Inc sold 2,169 shares on Apr 11, 2016. The Insider selling transaction was disclosed on Apr 12, 2016 to the Securities and Exchange Commission. The shares were sold at $68.00 per share for a total value of $147,492.00.

Company has been under the radar of several Street Analysts.DexCom is Reiterated by The Benchmark Company to Buy while Lowering the Price Target of the company shares to $ 86 from a previous price target of $105 . The Rating was issued on Feb 24, 2016.DexCom is Downgraded by Robert W. Baird to Neutral while Lowering the Price Target of the company shares to $ 74 from a previous price target of $100 . Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Feb 8, 2016.

Currently the company Insiders own 4.7% of DexCom shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -6.58%.Institutional Investors own 92.17% of DexCom shares.During last six month period, the net percent change held by insiders has seen a change of -11.51%.

Shares of DexCom (DXCM) ended Monday, Apr 11, 2016 session in red amid volatile trading. The shares closed down -1.28 points or -1.88% at $66.8 with 6,05,144 shares getting traded. Post opening the session at $68, the shares hit an intraday low of $66.49 and an intraday high of $68.27 and the price vacillated in this range throughout the day. The company has a market cap of $5,460 M and the number of outstanding shares has been calculated to be 8,17,40,827 shares. The 52-week high of DexCom is $103.29 and the 52-week low is $47.92.

DexCom Money Flow Index Chart

Dexcom Inc. (Dexcom) is a medical device company. The Company is focused on the design development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4 DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patient’s receiver and an application on the patient’s iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers who can remotely monitor a patient’s glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpot’s data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.

Leave a Reply

DexCom - Is it time to Sell?

Top Brokerage Firms are advising their investors on DexCom. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.